Literature DB >> 12141823

Plasma leptin and TNF-alpha levels in chronic hepatitis C patients and their relationship to hepatic fibrosis.

Javier Crespo1, Montserrat Rivero, Emilio Fábrega, Amalía Cayón, José Antonio Amado, Maria Teresa García-Unzeta, Fernando Pons-Romero.   

Abstract

The aim of this study was to examine the possible relationship between the plasma levels of leptin and tumor necrosis factor (TNF)-alpha and the stage of hepatic fibrosis in a cohort of patients with chronic hepatitis C. Leptin and TNF levels were measured by RIA in 135 patients and in 75 age- and sex-matched controls. Liver disease was evaluated by the stage of fibrosis and the extent of inflammatory infiltrate in the liver biopsy. Leptin levels correlated with BMI values in healthy controls and in patients with chronic hepatitis C (men, r = 0.61, P = 0.0001; women, r = 0.68, P = 0.003). Leptin levels increased as hepatic fibrosis stage progressed both in male and in female patients (P < 0.001); also, TNF levels were higher in patients with an advanced stage of fibrosis (P = 0.006). In these patients, levels of leptin increased according to the progression of the stage of fibrosis; these data suggest that leptin may play a role in the regulation of hepatic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12141823     DOI: 10.1023/a:1015835606718

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  The role of leptin in human physiology.

Authors:  M Rosenbaum; R L Leibel
Journal:  N Engl J Med       Date:  1999-09-16       Impact factor: 91.245

2.  Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis.

Authors:  R Testa; R Franceschini; E Giannini; A Cataldi; F Botta; A Fasoli; P Tenerelli; E Rolandi; T Barreca
Journal:  J Hepatol       Date:  2000-07       Impact factor: 25.083

3.  Transdifferentiation of rat hepatic stellate cells results in leptin expression.

Authors:  J J Potter; L Womack; E Mezey; F A Anania
Journal:  Biochem Biophys Res Commun       Date:  1998-03-06       Impact factor: 3.575

4.  Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.

Authors:  E Giannini; F Botta; A Cataldi; G L Tenconi; P Ceppa; T Barreca; R Testa
Journal:  Hepatogastroenterology       Date:  1999 Jul-Aug

5.  Systemic administration of lipopolysaccharide increases plasma leptin levels: blockade by soluble interleukin-1 receptor.

Authors:  J Francis; P S MohanKumar; S M MohanKumar; S K Quadri
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

6.  Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments].

Authors:  G Wolf; A Hamann; D C Han; U Helmchen; F Thaiss; F N Ziyadeh; R A Stahl
Journal:  Kidney Int       Date:  1999-09       Impact factor: 10.612

7.  Leptin in CAPD patients: serum concentrations and peritoneal loss.

Authors:  A Kagan; N Haran; L Leschinsky; N Shuali; J Rapoport
Journal:  Nephrol Dial Transplant       Date:  1999-02       Impact factor: 5.992

8.  Sex differences in circulating human leptin pulse amplitude: clinical implications.

Authors:  J Licinio; A B Negrão; C Mantzoros; V Kaklamani; M L Wong; P B Bongiorno; P P Negro; A Mulla; J D Veldhuis; L Cearnal; J S Flier; P W Gold
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

9.  Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects.

Authors:  F Corica; A Allegra; A Corsonello; M Buemi; G Calapai; A Ruello; V Nicita Mauro; D Ceruso
Journal:  Int J Obes Relat Metab Disord       Date:  1999-04

10.  Expression of leptin and its receptor in the human stomach.

Authors:  H Mix; M P Manns; S Wagner; A Widjaja; G Brabant
Journal:  Gastroenterology       Date:  1999-08       Impact factor: 22.682

View more
  26 in total

Review 1.  Potential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis.

Authors:  Michał Kukla; Włodzimierz Mazur; Rafał J Bułdak; Krystyna Zwirska-Korczala
Journal:  Mol Med       Date:  2011-07-05       Impact factor: 6.354

2.  The pattern of IL-24/mda-7 and its cognate receptors expression following activation of human hepatic stellate cells.

Authors:  Iman Jamhiri; Seyed Younes Hosseini; Davood Mehrabani; Zahra Khodabandeh; Ramin Yaghobi; Razieh Dowran; Saber Zahri
Journal:  Biomed Rep       Date:  2017-06-21

Review 3.  Hepatitis C virus induced insulin resistance impairs response to anti viral therapy.

Authors:  Abdel-Rahman El-Zayadi; Mahmoud Anis
Journal:  World J Gastroenterol       Date:  2012-01-21       Impact factor: 5.742

4.  Adipokines, cytokines and body fat stores in hepatitis C virus liver steatosis.

Authors:  Emilio González-Reimers; Javier López-Prieto; Geraldine Quintero-Platt; Ricardo Pelazas-González; M Remedios Alemán-Valls; Onán Pérez-Hernández; M José de-la-Vega-Prieto; M Angeles Gómez-Rodríguez; Candelaria Martín-González; Francisco Santolaria-Fernández
Journal:  World J Hepatol       Date:  2016-01-08

Review 5.  Liver steatosis in hepatitis C patients.

Authors:  Emilio González-Reimers; Geraldine Quintero-Platt; Melchor Rodríguez-Gaspar; Remedios Alemán-Valls; Onán Pérez-Hernández; Francisco Santolaria-Fernández
Journal:  World J Hepatol       Date:  2015-06-08

Review 6.  The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?

Authors:  Luca Valenti; Anna Ludovica Fracanzani; Silvia Fargion
Journal:  Semin Immunopathol       Date:  2009-05-14       Impact factor: 9.623

Review 7.  Pathogenesis of liver cirrhosis.

Authors:  Wen-Ce Zhou; Quan-Bao Zhang; Liang Qiao
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 8.  Molecular mechanisms of insulin resistance in chronic hepatitis C.

Authors:  Mark W Douglas; Jacob George
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

Review 9.  Pathogenesis and management issues for non-alcoholic fatty liver disease.

Authors:  Marko Duvnjak; Ivan Lerotić; Neven Barsić; Vedran Tomasić; Lucija Virović Jukić; Vedran Velagić
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

10.  Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.

Authors:  G Svegliati-Baroni; E Bugianesi; T Bouserhal; F Marini; F Ridolfi; F Tarsetti; F Ancarani; E Petrelli; E Peruzzi; M Lo Cascio; M Rizzetto; G Marchesini; A Benedetti
Journal:  Gut       Date:  2007-03-28       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.